Literature DB >> 11000507

Maternal thromboxane and prostacyclin levels in relation to fetal birth weight.

C L de Jong1, K M Paarlberg, H P van Geijn, G J van Kamp, H van Dis, G A Dekker.   

Abstract

OBJECTIVE: To analyse whether pregnancies resulting in a small for gestational age neonate are preceded by a prostacyclin deficiency or an imbalance between thromboxane and prostacyclin. STUDY
DESIGN: At five fixed time points during pregnancy, 24-h urine samples were collected for the measurement of thromboxane and prostacyclin metabolites thromboxane-B(2) (TXB(2)) and 6-keto-prostaglandin F(1alpha) (6-keto-PGF(1alpha)). In order to study trend differences between pregnancies with appropriate (AGA; n=26) and small for gestational age neonates (SGA; n=17), trend analysis with simple contrasts were accomplished for TXB(2), 6-keto-PGF(1alpha) and the TXB(2)/6-keto-PGF(1alpha) ratio.
RESULTS: Trend analysis showed higher TXB(2) levels and higher TXB(2)/6-keto-PGF(1alpha) ratios in patients with SGA versus AGA newborns. No statistically significant difference in 6-keto-PGF(1alpha) excretion between patients with SGA and AGA newborns was detected.
CONCLUSION: The birth of an SGA neonate is not preceded by prostacyclin deficiency. With ongoing pregnancy an imbalance between thromboxane and prostacyclin becomes more obvious in pregnancies with SGA newborns.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000507     DOI: 10.1016/s0301-2115(00)00266-9

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  Vitamin E: maternal concentrations are associated with fetal growth.

Authors:  Theresa O Scholl; Xinhua Chen; Melissa Sims; T Peter Stein
Journal:  Am J Clin Nutr       Date:  2006-12       Impact factor: 7.045

2.  Markers of oxidative stress and systemic vasoconstriction in pregnant women drinking > or =48 g of alcohol per day.

Authors:  Caroline Signore; Sofía Aros; Jason D Morrow; James Troendle; Mary R Conley; Elizabeth Y Flanigan; Fernando Cassorla; James L Mills
Journal:  Alcohol Clin Exp Res       Date:  2008-08-18       Impact factor: 3.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.